IDEAYA Biosciences 8-K Report: Key Insights from February 10, 2025

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: IDEAYA Biosciences, Inc.
• CIK Number: 0001676725
• SEC Central Index Key (CIK): 0001676725
• Company Type: Publicly traded entity.
• Ticker Symbol: IDYA
• Exchange: NASDAQ

2. Address:

• Location: 5000 Shoreline Court, Suite 300, South San Francisco, CA 94080
• Phone Number: (650) 443-6209

3. Filing Details:

• Form Type: 8-K (used to report major events that shareholders should know about)
• Filing Date: February 10, 2025
• Period Covered: The report pertains to a specific date, February 10, 2025.

4. Financial Instrument:

• Security: Common Stock
• Par Value: $0.0001 per share

5. Context Information:

• The report references a specific schema (idya-20250210.xsd), indicating it follows a particular format for XBRL (eXtensible Business Reporting Language) filings.

6. Important Dates:

• Start Date of Reporting Period: February 10, 2025
• End Date of Reporting Period: February 10, 2025

Overall, this report likely includes important disclosures related to IDEAYA Biosciences that could impact investors' understanding and assessment of the company's financial health or significant events occurring on that date. Further analysis of the content of the 8-K would be required to extract specific events or financial impacts.